Ofatumumab As A Combination Therapy Versus Other Treatment Regimens in Patients with Untreated, Relapsed or Refractory Chronic Lymphocytic Leukaemia- A Systematic Review of Randomised Controlled Trials
Abstract
Authors
HR Gadi P Patel S Shaikh MK Rai